Application Sponsors
ANDA 206854 | TEVA PHARMS USA INC | |
Marketing Status
None (Tentative Approval) | 001 |
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 10MG | 0 | DALFAMPRIDINE | DALFAMPRIDINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2016-07-19 | STANDARD |
Submissions Property Types
CDER Filings
TEVA PHARMS USA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 206854
[companyName] => TEVA PHARMS USA INC
[docInserts] => ["",""]
[products] => [{"drugName":"DALFAMPRIDINE","activeIngredients":"DALFAMPRIDINE","strength":"10MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"07\/19\/2016","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2016-07-19
)
)